- L’esperienza relativa alle patologie dermatologiche, tra cui la psoriasi, è differente nei pazienti non caucasici rispetto ai pazienti caucasici.
- L’obiettivo di questa revisione della letteratura è stato determinare le problematiche e le esigenze non risolte associate all’accesso alle cure, alla diagnosi e al trattamento della psoriasi nei pazienti non caucasici in Canada e negli Stati Uniti d’America.
- Rispetto ai pazienti caucasici con psoriasi, i soggetti non caucasici possono avere meno familiarità e differenti tassi di trattamento con i biologici, una maggior tendenza all’ospedalizzazione e un differente accesso alle cure. Inoltre, i pazienti non caucasici sono spesso sottorappresentati nei trial clinici.
Abstract
The experience of dermatological conditions such as psoriasis is different for people with skin of color (SoC) than for white individuals. The objective of this literature review was to understand challenges and unmet needs associated with access to care, diagnosis, and treatment of psoriasis among people with SoC in Canada and the United States. The review focused on studies published in the last 5 years. After screening 919 unique records, 26 studies were included. Importantly, lack of culturally competent care was identified as a key unmet need for psoriasis among people with SoC. In addition, cost of care and cultural views of psoriasis may influence decisions to seek care among people with SoC. Baseline patient characteristics in psoriasis studies and the prevalence/incidence of psoriasis vary across racial/ethnic groups, which may reflect differences in the rate and/or timing of diagnosis. The presentation of psoriasis differs across racial/ethnic groups, which may contribute to challenges in proper and timely diagnosis. Compared with white patients with psoriasis, individuals with SoC may be less familiar with and have different rates of treatment with biologic therapies for psoriasis, are more likely to be hospitalized for psoriasis, and their access to physicians may differ. Further, people with SoC are underrepresented in clinical trials of psoriasis therapies. Overall, the results of this literature review suggest that people with psoriasis and SoC face unique challenges in their disease experience. It is essential that clinicians and other stakeholders recognize and address these disparities to ensure equitable care.